+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Fungal Protein Market by Type, Nature andApplication: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • ID: 5439820
  • Report
  • July 2021
  • Region: Global
  • 302 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Cayman Chemical Company
  • DuPont de Nemours Inc.
  • Galactic
  • Mayasan Biotech
  • Merck Group
  • Royal DSM
Fungal protein is a protein derived from fungi-based sustainable food source. It comprises yeast-based protein and fusarium venenatum based proteins. Numerous attributes of fungal proteins such as rich in proteins, vitamins, folic acid, and minerals makes it an ideal choice for use in both human food & beverages as well as animal feed applications. It has higher weight percentage protein content than other common plant or fungal sources of protein. The global fungal protein market size was valued at $156.6 million in 2020, and is expected to reach $386.6 million by 2030, registering a CAGR of 9.5% from 2021 to 2030.



Health-conscious individuals choose functional food that keep them healthy and fit. The market growth is accredited to the demand for functional and processed food and as flavoring ingredients in baking and brewing. Increase in demand for ready-to-eat food due to increase in the number of working women and rise in urban population boosts the demand for fungal protein. Ample usage of cellulosic biofuels, together with the probiotic functional food among individuals, further fuels the market growth. High cholesterol levels, rise in obesity, and prevalence of diabetes drive the market for making medicines used for immune stimulation to improve the immune system. However, dearth of molasses is expected to hamper the market growth.

Researchers have found that excessive use of monosodium glutamate leads to side effects such as headache, weakness, numbness, flushing, and tingling. In addition, people are also changing their food habits and increasing the consumption of healthy food. Therefore, manufacturers of food & beverages are replacing yeast for the monosodium Glutamate. Autolyzed yeast is the good substitute for monosodium glutamate as it is cheaper and is comparatively healthier option. This surge in the usage of autolyzed yeast propels the growth of the market.

The fungal protein market is segmented on the basis of type, nature, application, and region. Based on type, the market is divided into yeast and Fusarium Venenatum. Based on nature, it is categorized into organic and conventional. Food & beverages, animal nutrition, pharmaceuticals, and others are the application of the fungal protein market.

The major players in the fungal protein market are AB Mauri, Angel Yeast, Alltech, Halcyon Proteins, Kerry Group, Lallemand, Inc., Royal DSM., Sensient Technologies Corporation, and Specialty Biotech Co.,Ltd.

Key market benefits for stakeholders

  • The study provides an in-depth analysis of the global fungal protein market, with current and future trends to explain the imminent investment pockets in the market.
  • Current and future trends are outlined in the report to determine the overall market attractiveness and single out profitable trends to gain a stronger foothold in the market.
  • The report provides information regarding drivers, restraints, and opportunities with impact analysis.
  • A quantitative analysis of the current market and estimation for the same from 2020 to 2030 is provided to showcase the financial competency of the market.
  • Porter’s Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier–buyer network.
  • Value chain analysis in the report provides a clear understanding of the roles of stakeholders involved in the value chain.
  • Competitive intelligence highlights the business practices followed by the leading market players across various regions
Frequently Asked Questions about the Global Fungal Protein Market

What is the estimated value of the Global Fungal Protein Market?

The Global Fungal Protein Market was estimated to be valued at $156.6 million in 2020.

What is the growth rate of the Global Fungal Protein Market?

The growth rate of the Global Fungal Protein Market is 9.5%, with an estimated value of $386.6 million by 2030.

What is the forecasted size of the Global Fungal Protein Market?

The Global Fungal Protein Market is estimated to be worth $386.6 million by 2030.

Who are the key companies in the Global Fungal Protein Market?

Key companies in the Global Fungal Protein Market include Cayman Chemical Company, Chihon Biotechnology Co. Ltd., Duke Thomson's India Pvt. Ltd, DuPont de Nemours Inc., Galactic, Mayasan Biotech, Merck Group, Royal DSM and Siveele B.V..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cayman Chemical Company
  • DuPont de Nemours Inc.
  • Galactic
  • Mayasan Biotech
  • Merck Group
  • Royal DSM
CHAPTER 1: INTRODUCTION
1.1. Key benefits for stakeholders
1.2. Key market segments
1.3. Research methodology
1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.1.1. Global Fungal protein Market: Segmentation
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top impacting factors
3.4. Top players positioning
3.5. Premium Insights
3.6. Value chain analysis
3.7. Porter’s five forces analysis
3.7.1. Moderate bargaining power of suppliers
3.7.2. Moderate bargaining power of buyers
3.7.3. Moderate threat of substitution
3.7.4. Moderate threat of new entrants
3.7.5. Moderate Intensity of competitive rivalry
3.8. Market dynamics
3.8.1. Drivers
3.8.1.1. Change in dietary patterns fuels consumption of processed foods
3.8.1.2. Rise in consumer demand for allergen-free foods
3.8.1.3. Rising disposable income in developing countries
3.8.1.4. Consumer awareness about healthy diet
3.8.2. Restraints
3.8.2.1. Availability of healthier substitutes
3.8.2.2. Undefined regulatory guidelines
3.8.3. Opportunities
3.8.3.1. Product innovation and rise in demand for protein ingredients
3.8.3.2. Increase in use of yeast extract in processed food industry
3.9. Market share analysis
3.9.1. By Type
3.9.2. By Nature
3.9.3. By Application
3.9.4. By region
3.10. Impact of COVID-19 on the Fungal protein market

CHAPTER 4: FUNGAL PROTEIN MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Yeast
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Fusarium Venenatum
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

CHAPTER 5: FUNGAL PROTEIN MARKET, NATURE
5.1. Overview
5.1.1. Market size and forecast
5.2. Organic
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Conventional
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country

CHAPTER 6: FUNGAL PROTEIN MARKET, APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Food & beverages
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.2.4. Processed Food
6.2.4.1. Key market trends, growth factors, and opportunities
6.2.5. Beverages
6.2.5.1. Key market trends, growth factors, and opportunities
6.2.6. Bakery
6.2.6.1. Key market trends, growth factors, and opportunities
6.2.7. Dairy
6.2.7.1. Key market trends, growth factors, and opportunities
6.2.8. Others
6.2.8.1. Key market trends, growth factors, and opportunities
6.3. Animal nutrition
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. Pharmaceutical
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
6.5. Others
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market analysis, by country

CHAPTER 7: FUNGAL PROTEIN MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast, by region
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Nature
7.2.4. Market size and forecast, by Application
7.2.5. Market size and forecast, by country
7.2.5.1. U. S.
7.2.5.1.1. Market size and forecast, by Type
7.2.5.1.2. Market size and forecast, by Nature
7.2.5.1.3. Market size and forecast, by Application
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Type
7.2.5.2.2. Market size and forecast, by Nature
7.2.5.2.3. Market size and forecast, by Application
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Type
7.2.5.3.2. Market size and forecast, by Nature
7.2.5.3.3. Market size and forecast, by Application
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Nature
7.3.4. Market size and forecast, by Application
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Type
7.3.5.1.2. Market size and forecast, by Nature
7.3.5.1.3. Market size and forecast, by Application
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Type
7.3.5.2.2. Market size and forecast, by Nature
7.3.5.2.3. Market size and forecast, by Application
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Type
7.3.5.3.2. Market size and forecast, by Nature
7.3.5.3.3. Market size and forecast, by Application
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Type
7.3.5.4.2. Market size and forecast, by Nature
7.3.5.4.3. Market size and forecast, by Application
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Type
7.3.5.5.2. Market size and forecast, by Nature
7.3.5.5.3. Market size and forecast, by Application
7.3.5.6. Russia
7.3.5.6.1. Market size and forecast, by Type
7.3.5.6.2. Market size and forecast, by Nature
7.3.5.6.3. Market size and forecast, by Application
7.3.5.7. Rest of Europe
7.3.5.7.1. Market size and forecast, by Type
7.3.5.7.2. Market size and forecast, by Nature
7.3.5.7.3. Market size and forecast, by Application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Nature
7.4.4. Market size and forecast, by Application
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Market size and forecast, by Type
7.4.5.1.2. Market size and forecast, by Nature
7.4.5.1.3. Market size and forecast, by Application
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by Type
7.4.5.2.2. Market size and forecast, by Nature
7.4.5.2.3. Market size and forecast, by Application
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Type
7.4.5.3.2. Market size and forecast, by Nature
7.4.5.3.3. Market size and forecast, by Application
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Type
7.4.5.4.2. Market size and forecast, by Nature
7.4.5.4.3. Market size and forecast, by Application
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Type
7.4.5.5.2. Market size and forecast, by Nature
7.4.5.5.3. Market size and forecast, by Application
7.4.5.6. Thailand
7.4.5.6.1. Market size and forecast, by Type
7.4.5.6.2. Market size and forecast, by Nature
7.4.5.6.3. Market size and forecast, by Application
7.4.5.7. Srilanka
7.4.5.7.1. Market size and forecast, by Type
7.4.5.7.2. Market size and forecast, by Nature
7.4.5.7.3. Market size and forecast, by Application
7.4.5.8. Rest of Asia-Pacific
7.4.5.8.1. Market size and forecast, by Type
7.4.5.8.2. Market size and forecast, by Nature
7.4.5.8.3. Market size and forecast, by Application
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Nature
7.5.4. Market size and forecast, by Application
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Type
7.5.5.1.2. Market size and forecast, by Nature
7.5.5.1.3. Market size and forecast, by Application
7.5.5.2. Argentina
7.5.5.2.1. Market size and forecast, by Type
7.5.5.2.2. Market size and forecast, by Nature
7.5.5.2.3. Market size and forecast, by Application
7.5.5.3. United Arab Emirates
7.5.5.3.1. Market size and forecast, by Type
7.5.5.3.2. Market size and forecast, by Nature
7.5.5.3.3. Market size and forecast, by Application
7.5.5.4. Saudi Arabia
7.5.5.4.1. Market size and forecast, by Type
7.5.5.4.2. Market size and forecast, by Nature
7.5.5.4.3. Market size and forecast, by Application
7.5.5.5. South Africa
7.5.5.5.1. Market size and forecast, by Type
7.5.5.5.2. Market size and forecast, by Nature
7.5.5.5.3. Market size and forecast, by Application
7.5.5.6. Turkey
7.5.5.6.1. Market size and forecast, by Type
7.5.5.6.2. Market size and forecast, by Nature
7.5.5.6.3. Market size and forecast, by Application
7.5.5.7. Rest of LAMEA
7.5.5.7.1. Market size and forecast, by Type
7.5.5.7.2. Market size and forecast, by Nature
7.5.5.7.3. Market size and forecast, by Application

CHAPTER 8: COMPETITION LANDSCAPE
8.1. Top winning strategies
8.2. Product mapping
8.3. Competitive dashboard
8.4. Competitive heat map
8.5. Key developments
8.5.1. Acquisition
8.5.2. Business Expansion
8.5.3. Product Launch

CHAPTER 9: COMPANY PROFILES
9.1. AB Mauri
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. R&D Expenditure
9.1.7. Business performance
9.1.8. Key strategic moves and developments
9.2. Angel Yeast
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Product portfolio
9.2.5. Key strategic moves and developments
9.3. Alltech
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Product portfolio
9.4. Biospringer
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Product portfolio
9.4.5. Key strategic moves and developments
9.5. Halcyon Proteins
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Product portfolio
9.6. Kerry Group
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. R&D expenditure
9.6.7. Business performance
9.6.8. Key strategic moves and developments
9.7. Lallemand, Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Product portfolio
9.7.5. Key strategic moves and developments
9.8. Royal DSM
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. R&D Expenditure
9.8.7. Business performance
9.8.8. Key strategic moves and developments
9.9. Sensient Technologies Corporation
9.9.1. Company overview
9.9.2. Key executive
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. R&D expenditure
9.9.7. Business performance
9.10. Specialty Biotech Co.,Ltd.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Product portfolio


LIST OF TABLES
TABLE 01. GLOBAL FUNGAL PROTEIN MARKET REVENUE, BY TYPE, 2021-2030 ($MILLION)
TABLE 02. FUNGAL PROTEIN MARKET REVENUE FOR YEAST, BY REGION, 2021-2030 ($MILLION)
TABLE 03. FUNGAL PROTEIN MARKET FOR FUSARIUM VENENATUM, BY REGION 2020-2030 ($MILLION)
TABLE 04. GLOBAL FUNGAL PROTEIN MARKET REVENUE, BY NATURE, 2021-2030($MILLION)
TABLE 05. FUNGAL PROTEIN MARKET REVENUE FOR ORGANIC, BY REGION, 2020-2030 ($MILLION)
TABLE 06. FUNGAL PROTEIN MARKET REVENUE FOR CONVENTIONAL, BY REGION, 2020-2030 ($MILLION)
TABLE 07. GLOBAL FUNGAL PROTEIN MARKET REVENUE, BY APPLICATION, 2021-2030($MILLION)
TABLE 08. FUNGAL PROTEIN MARKET REVENUE FOR FOOD & BEVERAGES, BY REGION, 2020-2030 ($MILLION)
TABLE 09. FUNGAL PROTEIN MARKET REVENUE FOR ANIMAL NUTRITION, BY REGION, 2020-2030 ($MILLION)
TABLE 10. FUNGAL PROTEIN MARKET REVENUE FOR PHARMACEUTICAL, BY REGION, 2020-2030 ($MILLION)
TABLE 11. FUNGAL PROTEIN MARKET REVENUE FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 12. FUNGAL PROTEIN MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 13. NORTH AMERICA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 14. NORTH AMERICA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 15. NORTH AMERICA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 16. NORTH AMERICA FUNGAL PROTEIN MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 17. U.S. FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 18. U.S. FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 19. U.S. FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 20. CANADA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 21. CANADA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 22. CANADA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 23. MEXICO FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 24. MEXICO FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 25. MEXICO FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 26. EUROPE FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 27. EUROPE FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 28. EUROPE FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 29. EUROPE FUNGAL PROTEIN MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 30. THE GERMANY FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 31. GERMANY FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 32. GERMANY FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 33. FRANCE FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 34. FRANCE FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 35. FRANCE FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 36. UK FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 37. UK FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 38. UK FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 39. ITALY FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 40. ITALY FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 41. ITALY FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 42. SPAIN FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 43. SPAIN FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 44. SPAIN FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 45. RUSSIA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 46. RUSSIA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 47. RUSSIA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 48. REST OF EUROPE FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 49. REST OF EUROPE FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 50. REST OF EUROPE FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 51. ASIA-PACIFIC FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 52. ASIA-PACIFIC FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 53. ASIA-PACIFIC FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 54. ASIA-PACIFIC FUNGAL PROTEIN MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 55. CHINA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 56. CHINA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 57. CHINA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 58. JAPAN FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 59. JAPAN FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 60. JAPAN FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 61. INDIA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 62. INDIA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 63. INDIA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 64. AUSTRALIA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 65. AUSTRALIA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 66. AUSTRALIA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 67. SOUTH KOREA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 68. SOUTH KOREA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 69. SOUTH KOREA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 70. THAILAND FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 71. THAILAND FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 72. THAILAND FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 73. SRI LANKA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 74. SRI LANKA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 75. SRI LANKA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 76. REST OF ASIA-PACIFIC FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 77. REST OF ASIA-PACIFIC FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 78. REST OF ASIA-PACIFIC FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 79. LAMEA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 80. LAMEA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 81. LAMEA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 82. LAMEA FUNGAL PROTEIN MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 83. BRAZIL FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 84. BRAZIL FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 85. BRAZIL FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 86. ARGENTINA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 87. ARGENTINA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 88. ARGENTINA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 89. UNITED ARAB EMIRATES FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 90. UNITED ARAB EMIRATES FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 91. UNITED ARAB EMIRATES FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 92. SAUDI ARABIA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 93. SAUDI ARABIA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 94. SAUDI ARABIA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 95. SOUTH AFRICA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 96. SOUTH AFRICA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 97. SOUTH AFRICA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 98. TURKEY FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 99. TURKEY FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 100. TURKEY FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 101. REST OF LAMEA FUNGAL PROTEIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 102. REST OF LAMEA FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030 ($MILLION)
TABLE 103. REST OF LAMEA FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 104. AB MAURI: KEY EXECUTIVES
TABLE 105. AB MAURI: COMPANY SNAPSHOT
TABLE 106. AB MAURI: OPERATING SEGMENTS
TABLE 107. AB MAURI: PRODUCT PORTFOLIO
TABLE 108. AB MAURI: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 109. AB MAURI: NET SALES, 2018-2020 ($MILLION)
TABLE 110. ANGEL YEAST: KEY EXECUTIVES
TABLE 111. ANGEL YEAST: COMPANY SNAPSHOT
TABLE 112. ANGEL YEAST: PRODUCT PORTFOLIO
TABLE 113. ALLTECH: KEY EXECUTIVES
TABLE 114. ALLTECH: COMPANY SNAPSHOT
TABLE 115. ALLTECH: PRODUCT PORTFOLIO
TABLE 116. BIOSPRINGER: KEY EXECUTIVES
TABLE 117. BIOSPRINGER: COMPANY SNAPSHOT
TABLE 118. BIOSPRINGER: PRODUCT PORTFOLIO
TABLE 119. HALCYON PROTEINS: KEY EXECUTIVES
TABLE 120. HALCYON PROTEINS: COMPANY SNAPSHOT
TABLE 121. HALCYON PROTEINS: PRODUCT PORTFOLIO
TABLE 122. KERRY GROUP: KEY EXECUTIVES
TABLE 123. KERRY GROUP: COMPANY SNAPSHOT
TABLE 124. KERRY GROUP: OPERATING SEGMENTS
TABLE 125. KERRY GROUP: PRODUCT PORTFOLIO
TABLE 126. KERRY GROUP: R&D EXPENDITURE, 2017-2019 ($MILLION)
TABLE 127. KERRY GROUP: NET SALES, 2017-2019 ($MILLION)
TABLE 128. LALLEMAND, INC.: KEY EXECUTIVES
TABLE 129. LALLEMAND, INC.: COMPANY SNAPSHOT
TABLE 130. LALLEMAND, INC.: PRODUCT PORTFOLIO
TABLE 131. ROYAL DSM: KEY EXECUTIVES
TABLE 132. ROYAL DSM: COMPANY SNAPSHOT
TABLE 133. ROYAL DSM: OPERATING SEGMENTS
TABLE 134. ROYAL DSM: PRODUCT PORTFOLIO
TABLE 135. ROYAL DSM.: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 136. ROYAL DSM: NET SALES, 2018-2020 ($MILLION)
TABLE 137. SENSIENT: KEY EXECUTIVE
TABLE 138. SENSIENT: COMPANY SNAPSHOT
TABLE 139. SENSIENT: OPERATING SEGMENTS
TABLE 140. SENSIENT: PRODUCT PORTFOLIO
TABLE 141. SENSIENT: R&D EXPENDITURE, 2017-2019 ($MILLION)
TABLE 142. SENSIENT: NET SALES, 2017-2019 ($MILLION)
TABLE 143. SPECIALTY BIOTECH CO.,LTD.: COMPANY SNAPSHOT
TABLE 144. SPECIALTY BIOTECH CO.,LTD.: PRODUCT PORTFOLIO


LIST OF FIGURES
FIGURE 01. GLOBAL FUNGAL PROTEIN MARKET SNAPSHOT
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP IMPACTING FACTORS
FIGURE 04. VALUE CHAIN ANALYSIS
FIGURE 05. FUNGAL PROTEIN MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 06. FUNGAL PROTEIN MARKET REVENUE, BY TYPE, 2021-2030 ($MILLION)
FIGURE 07. COMPARATIVE SHARE ANALYSIS OF FUNGAL PROTEINKS MARKET FOR YEAST, BY COUNTRY, 2020 & 2030(%)
FIGURE 08. COMPARATIVE SHARE ANALYSIS FOR FUNGAL PROTEIN MARKET FOR FUSARIUM VENENATUM, BY COUNTRY, 2020 & 2030(%)
FIGURE 09. FUNGAL PROTEIN MARKET, BY NATURE, 2020-2030
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF FUNGAL PROTEIN MARKET FOR ORGANIC, BY COUNTRY, 2020 & 2030(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF FUNGAL PROTEIN MARKET FOR CONVENTIONAL, BY COUNTRY, 2020 & 2030 (%)
FIGURE 12. FUNGAL PROTEIN MARKET, BY APPLICATION, 2020-2030
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF FUNGAL PROTEIN MARKET FOR FOOD & BEVERAGES, BY COUNTRY, 2020 & 2030(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF FUNGAL PROTEIN MARKET FOR ANIMAL NUTRITION, BY COUNTRY, 2020 & 2030 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF FUNGAL PROTEIN MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF FUNGAL PROTEIN MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030(%)
FIGURE 17. FUNGAL PROTEIN MARKET, BY REGION, 2020 (%)
FIGURE 18. U.S. FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 19. CANADA FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 20. MEXICO FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 21. GERMANY FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 22. FRANCE FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 23. UK FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 24. ITALY FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 25. SPAIN FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 26. RUSSIA FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 27. REST OF EUROPE FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 28. CHINA FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 29. JAPAN NISN MARKET, 2020-2030 ($MILLION)
FIGURE 30. INDIA FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 31. AUSTRALIA FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 32. SOUTH KOREA FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 33. THAILAND FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 34. SRILANKA FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 36. BRAZIL FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 37. ARGENTINA FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 38. UNITED ARAB EMIRATES FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 39. SAUDI ARABIA FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 40. SOUTH AFRICA FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 41. TURKEY FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 42. REST OF LAMEA FUNGAL PROTEIN MARKET, 2020-2030 ($MILLION)
FIGURE 43. TOP WINNING STRATEGIES, BY YEAR, 2017-2020*
FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2020* (%)
FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY, 2017-2020*
FIGURE 46. PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 47. COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 48. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 49. AB MAURI: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 50. AB MAURI: NET SALES, 2018-2020 ($MILLION)
FIGURE 51. AB MAURI: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 52. AB MAURI: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 53. KERRY GROUP: R&D EXPENDITURE, 2017-2019 ($MILLION)
FIGURE 54. KERRY GROUP: NET SALES, 2017-2019 ($MILLION)
FIGURE 55. KERRY GROUP: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 56. KERRY GROUP: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 57. ROYAL DSM: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 58. ROYAL DSM: NET SALES, 2018-2020 ($MILLION)
FIGURE 59. ROYAL DSM: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 60. SENSIENT: R&D EXPENDITURE, 2017-2019 ($MILLION)
FIGURE 61. SENSIENT: NET SALES, 2017-2019 ($MILLION)
FIGURE 62. SENSIENT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 63. SENSIENT: REVENUE SHARE BY REGION, 2019 (%)
Note: Product cover images may vary from those shown
  • Cayman Chemical Company
  • Chihon Biotechnology Co. Ltd.
  • Duke Thomson's India Pvt. Ltd
  • DuPont de Nemours Inc.
  • Galactic
  • Mayasan Biotech
  • Merck Group
  • Royal DSM
  • Santa Cruz Biotechnology Inc
  • Siveele B.V.
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...